Lin et al. reported miR-33b as a negative regulator of cell stemness and metastasis in breast cancer by targeting HMGA2, spalt-like transcription factor 4 (SALL4), and Twist1 [114]. The gene discussed is HMGA2; the disease is breast carcinoma.